| 000 | 01725 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515204916.0 | ||
| 264 | 0 | _c20110531 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1878-5050 | ||
| 024 | 7 |
_a10.1016/S1567-5688(09)71802-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoufi, Muhidien | |
| 245 | 0 | 0 |
_aGenetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R. _h[electronic resource] |
| 260 |
_bAtherosclerosis. Supplements _cDec 2009 |
||
| 300 |
_a5-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Twin Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aApolipoproteins _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aElectrophoresis |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xblood |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 |
_aTwins, Monozygotic _xgenetics |
| 700 | 1 | _aKurt, Bilgen | |
| 700 | 1 | _aSchweer, Horst | |
| 700 | 1 | _aSattler, Alexander M | |
| 700 | 1 | _aKlaus, Günter | |
| 700 | 1 | _aZschocke, Johannes | |
| 700 | 1 | _aSchaefer, Juergen R | |
| 773 | 0 |
_tAtherosclerosis. Supplements _gvol. 10 _gno. 5 _gp. 5-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1567-5688(09)71802-1 _zAvailable from publisher's website |
| 999 |
_c19501274 _d19501274 |
||